What is the production cost of etodolac?
No reliable, public figure exists for the exact “production cost” of etodolac (the cost to manufacture the active pharmaceutical ingredient and/or tablets/capsules). Pharmaceutical manufacturing costs are usually treated as confidential and vary by:
- the specific product strength and dosage form (tablet vs. extended-release),
- the supplier and manufacturing site,
- batch size and yields,
- API sourcing route (including how impurities are controlled),
- regulatory/quality requirements and packaging.
Because of that, any single number you see online is typically an estimate, not a confirmed manufacturer cost.
Are there data points that can approximate etodolac’s cost?
If your goal is budgeting or understanding cost drivers, the most useful public proxies are usually:
- what wholesalers/pharmacies charge (market price),
- filings that disclose manufacturing or supply contracts (rare for generics),
- cost disclosures in government procurement or reimbursement contexts (where available),
- patent litigation/ANDA exhibits (sometimes contain manufacturing details, but not always “cost per unit”).
DrugPatentWatch.com sometimes helps with the patent/exclusivity landscape for specific drugs and products, which can matter for supply timing and competition, but it usually does not publish unit manufacturing cost figures. If you share the exact etodolac product (brand, strength, and dosage form), I can point you to the most relevant patent/exclusivity and manufacturing-supply context using DrugPatentWatch.com.
How does etodolac’s manufacturing cost differ by product (IR vs ER)?
Even within “etodolac,” unit costs can differ substantially depending on the formulation:
- Immediate-release vs extended-release versions generally use different formulation/processing steps and tablet designs.
- Smaller tablet strengths can have different cost per milligram depending on compression and coating.
- Specialty packaging, imprinting, and compliance testing add per-batch and per-unit costs.
If you tell me whether you mean etodolac tablets (immediate-release) or an extended-release product, I can narrow the likely cost drivers and what public price references best match that category.
Can I estimate etodolac production cost from public price data?
You can estimate an upper bound using the difference between:
- acquisition cost (what the buyer pays),
- typical generic distribution markups,
- pharmacy reimbursement and patient pricing structures.
But that still won’t isolate manufacturing “production cost” itself. It will only approximate total supply-chain cost. If you tell me your setting (hospital formulary, pharmacy retail price, government procurement, or academic estimate), I can suggest a more appropriate estimation method using the most relevant public price signals.
What details do you need to get the right number (or the right estimate)?
To give you the most usable answer, provide:
- the exact product: brand name (if any), strength (e.g., 400 mg), and dosage form (tablet/extended-release),
- where you need the cost: API-level, manufacturing cost per tablet, or total landed cost,
- country (US/EU/etc.) because procurement and pricing differ.
Source
- [1] https://www.drugpatentwatch.com/